Today Sierra Leone is embarking on a nationwide campaign with the rVSV-ZEBOV vaccine, trademarked as Ervebo. The Ervebo vaccine, developed by Merck, is a single-dose vaccine. It works by using ...
As Ebola swept through Sierra Leone in 2014, there were no approved vaccines against the disease. In 2019, the WHO prequalified the Ervebo vaccine and Gavi formally approved the establishment of a ...
The new vaccine – known during its development as V920 (rVSVΔG-ZEBOV-GP) – will be distributed under the Ervebo brand name if approved by the EMA for active immunisation of individuals aged ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback